Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chemical & Pharmaceutical. Financial terms of the agreement have not been disclosed.
Subscribe to our email newsletter
Under the terms of the agreement, Standard Chemical & Pharmaceutical has the exclusive development and manufacturing rights and Cypress Pharmaceutical has exclusive US marketing rights of the generic drug products.
Max Draughn, Cypress Pharmaceutical’s CEO, said: “We are very pleased Standard has chosen to partner with us and utilize Cypress’s strong US marketing position. As a seasoned global pharmaceutical company with significant experience in development and manufacturing, Standard is a complementary and compelling partner with Cypress.”